H1B Salary Data

Home › Employers › Orion Medicines, Inc.

Orion Medicines, Inc.: H-1B salaries and sponsorship

Orion Medicines, Inc. filed 3 labor condition applications for H-1B and related visas in fiscal years 2023–2026; certified: 2. Median offered salary: $138,230.

Applications (LCAs)3
Certified2
Employer addressSan Francisco, CA
H-1B dependent employerNo
Median offered salary$138,230
Middle half of salaries$107,346–$169,115
10th–90th percentile$88,815–$187,646

Does Orion Medicines, Inc. sponsor H-1B visas?

Orion Medicines, Inc. filed 3 labor condition applications in fiscal years 2023–2026, the latest submitted on Feb 26, 2024. An LCA is the first step of an H-1B petition, so the employer has sponsored or prepared to sponsor H-1B workers; it does not guarantee sponsorship for any particular job. Check the employer's own job listings.

Salaries by job title

Job titleLCAsMedian salary
Staff Scientist2$200,000
Research Associate, Proteomics1$76,461

Applications by fiscal year

Fiscal yearLCAsMedian salary
FY20231$76,461
FY20242$200,000

Prevailing wage levels

The Department of Labor sets four prevailing wage levels for each occupation and area, from Level I (entry) to Level IV (fully competent). The employer picks the level that matches the job's requirements.

Where the jobs are

Occupations

Latest applications

Job titleBase salaryLocationSubmittedStart dateStatus
Staff Scientist$200,000–$225,000
H-1B1 (Singapore) · Level IV
Foster City, CAFeb 26, 2024Jun 19, 2024Certified
Staff Scientist$200,000–$225,000
H-1B1 (Singapore) · Level IV
Foster City, CAFeb 20, 2024Jun 19, 2024Denied
Research Associate, Proteomics$76,461–$108,000
Level I
Foster City, CASep 20, 2023Oct 2, 2023Certified

Salaries are the lower end of the wage offered on each application, converted to a yearly amount; statistics use certified full-time applications only. An LCA is not a visa approval and one LCA can cover several positions. Source: U.S. Department of Labor, OFLC LCA Disclosure Data, fiscal years 2023–2026 (latest decision Jun 30, 2026).